STOCK TITAN

908 Devices Launches Oligos Kit for its ZipChip CE-MS Device

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

908 Devices Inc. (NASDAQ: MASS) launched a new Oligos assay kit at the ASMS conference, designed for its ZipChip device, enabling rapid and accurate oligonucleotide analysis. The kit offers several advantages over traditional liquid chromatography, including:

  • No harsh ion-pairing reagents
  • Faster analysis
  • High-resolution, accurate mass identification

This advancement supports biopharmaceutical labs and enhances 908 Devices' position in the growing market for therapeutic oligonucleotides.

Positive
  • Launch of a new Oligos assay kit enhances product offering.
  • The kit enables faster and more accurate oligonucleotide analysis.
  • Supports growth in the therapeutic oligonucleotide sector.
Negative
  • None.

New kit provides a simple, rapid and cost-effective method for oligonucleotide analysis

PHILADELPHIA--(BUSINESS WIRE)-- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, announced at the American Society for Mass Spectrometry (ASMS) conference today a new Oligos assay kit for its ZipChip device that enables fast and accurate identification and quantitation of oligonucleotides. Using this new Oligos kit with the ZipChip device, biopharmaceutical lab personnel now have an easy method for high-resolution separation and mass spec sample introduction without the use of harsh ion-pairing reagents.

Traditional liquid chromatography (LC) workflows for oligonucleotide analysis are cumbersome and slow, and the use of ion-pairing reagents leads to frequent mass spec instrument maintenance and downtime. ZipChip, a plug-and-play open access platform, integrates with Thermo Fisher, Sciex, and Bruker mass spectrometers and leverages microfluidic-based Capillary Electrophoresis (CE) and electrospray ionization technology to minimize sample prep burden, perform high-resolution separations and directly introduce samples into a mass spec.

“Oligonucleotides is an exciting and rapidly growing therapeutic area for targeting genetic diseases,” said Maura Fitzpatrick, vice president of product management and marketing, 908 Devices. “We continue to enhance the capabilities of our ZipChip device and assay kits to enable our users to accelerate their workflows in critical-to-life applications.”

The ZipChip Oligos kit provides a fast and simple means to obtain high-resolution separation and mass spec data from a wide range of oligonucleotides. Users can benefit from:

  • Lack of harsh ion-pairing reagents
  • Orthogonal separation to LC
  • Analysis in minutes with minimal sample preparation and method development
  • High-resolution, accurate mass identification and quantitation with CE-MS

Visit booth #306 at ASMS to learn more about the ZipChip device, Oligos kit and other handheld and desktop mass spec devices from 908 Devices or visit www.908devices.com.

About 908 Devices

908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.

Media Contact

Katie Johnston

PAN Communications for 908 Devices

908devices@pancomm.com

Investor Contact

Carrie Mendivil

IR@908devices.com

Source: 908 Devices Inc.

FAQ

What is the new product launched by 908 Devices (MASS)?

908 Devices launched a new Oligos assay kit for the ZipChip device.

When was the Oligos assay kit announced?

The Oligos assay kit was announced at the ASMS conference.

What advantages does the Oligos assay kit provide?

The kit allows for rapid analysis, high-resolution separation, and eliminates harsh ion-pairing reagents.

How does the Oligos kit impact biopharmaceutical labs?

It simplifies and speeds up oligonucleotide analysis workflows in biopharmaceutical labs.

908 Devices Inc.

NASDAQ:MASS

MASS Rankings

MASS Latest News

MASS Stock Data

82.48M
34.66M
7.64%
71.2%
3.95%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States of America
BOSTON